BEAM
Price
$22.92
Change
+$1.64 (+7.71%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
2.15B
55 days until earnings call
LGND
Price
$166.24
Change
+$0.73 (+0.44%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
3.23B
50 days until earnings call
Interact to see
Advertisement

BEAM vs LGND

Header iconBEAM vs LGND Comparison
Open Charts BEAM vs LGNDBanner chart's image
Beam Therapeutics
Price$22.92
Change+$1.64 (+7.71%)
Volume$74.15K
Capitalization2.15B
Ligand Pharmaceuticals
Price$166.24
Change+$0.73 (+0.44%)
Volume$4.28K
Capitalization3.23B
BEAM vs LGND Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. LGND commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and LGND is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (BEAM: $21.28 vs. LGND: $165.51)
Brand notoriety: BEAM and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 84% vs. LGND: 128%
Market capitalization -- BEAM: $2.15B vs. LGND: $3.23B
BEAM [@Biotechnology] is valued at $2.15B. LGND’s [@Biotechnology] market capitalization is $3.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and LGND are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while LGND’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • LGND’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than LGND.

Price Growth

BEAM (@Biotechnology) experienced а +6.72% price change this week, while LGND (@Biotechnology) price change was -0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.28%. For the same industry, the average monthly price growth was +6.89%, and the average quarterly price growth was +33.83%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

LGND is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+3.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($3.23B) has a higher market cap than BEAM($2.15B). LGND YTD gains are higher at: 54.470 vs. BEAM (-14.194). LGND has higher annual earnings (EBITDA): -45.94M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. LGND (255M). LGND has less debt than BEAM: LGND (5.74M) vs BEAM (155M). LGND has higher revenues than BEAM: LGND (188M) vs BEAM (60.3M).
BEAMLGNDBEAM / LGND
Capitalization2.15B3.23B67%
EBITDA-414.33M-45.94M902%
Gain YTD-14.19454.470-26%
P/E RatioN/A46.19-
Revenue60.3M188M32%
Total Cash1.15B255M451%
Total Debt155M5.74M2,699%
FUNDAMENTALS RATINGS
LGND: Fundamental Ratings
LGND
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMLGND
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 21 days ago
78%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANIX31.420.20
+0.64%
Oakmark International Institutional
JICAX84.56N/A
N/A
JPMorgan US Sustainable Leaders A
ARCHX19.20N/A
N/A
Archer Balanced
PRDAX12.23N/A
N/A
Principal Diversified Real Asset A
TQSMX24.84N/A
N/A
T. Rowe Price Integrated US SMCC Eq